Clinical efficacy of Vortioxetine and escitalopram in the treatment of depression
Objectives: This study was aimed to investigate the efficacy and safety of vortioxetine hydrobromide in the treatment of major depressive disorder (MDD). Methods: One hundred and eighty patients with the newly diagnosed depression in our hospital between August 2018 and August 2019 were selected and...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Professional Medical Publications
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |